جست‌وجوی استاد و پژوهشگر

Kathleen M. Caronمشاهده پروفایل

استاد

• Cell Biology
• Physiology
• Lymphatic System
• +۵ مورد دیگر

Kathleen M. Caron is a Professor and Chair of the Department of Cell Biology and Physiology at the University of North Carolina (UNC) School of Medicine. Her research focuses on G protein-coupled receptor (GPCR) pathways, particularly adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) signaling, in lymphatic vascular development and gastrointestinal biology. University: University of North Carolina at Chapel Hill School: UNC School of Medicine Department: Department of Cell Biology and Physiology Research Interests: Dr. Caron's work investigates GPCR systems in lymphatic endothelial cell function, lymphangiogenesis, and neurovascular-gastrointestinal crosstalk. Key areas include: AM-CLR-RAMP2 signaling in developmental lymphangiogenesis CGRP's role in lacteal permeability and lipid absorption Lymphatic-epithelial interactions in gastrointestinal disease Pharmacological targeting of GPCRs for vascular and metabolic disorders VE-cadherin interactome in cardiac lymphatic maintenance Neuroinflammatory mechanisms in migraine pathophysiology Scientific Contributions: Her lab discovered the first pharmacologically-tractable GPCR system (AM-CLR) in lymphatic development and identified its role in human hydrops fetalis mutations. Recent studies explore CGRP signaling in meningeal lymphatics and metabolic dysregulation in lacteal-null models. Affiliations: Member of the UNC Center for Gastrointestinal Biology and Disease (CGIBD) and contributor to interdisciplinary research at UNC.

Ian Carrollمشاهده پروفایل

دانشیار

• Microbiome Research
• Gut-Brain Axis
• Nutritional Therapies
• +۳ مورد دیگر

Ian Carroll, PhD is an Associate Professor in the Department of Nutrition at the UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill. His research focuses on gastrointestinal biology and disease, with specific expertise in microbiome interactions. He directs the Carroll Lab and holds affiliations with the Center for Gastrointestinal Biology and Disease (CGIBD), where he serves as a Microbiome Focus Area investigator. Dr. Carroll's research centers on mechanisms through which intestinal microbiota and their metabolites influence gastrointestinal physiology, behavior, and weight regulation. His work spans microbiome dynamics in obesity, diabetes, and eating disorders , with particular emphasis on short-chain fatty acid physiology , gut-brain axis communication , and nutritional interventions . His laboratory has pioneered techniques for biological sample collection and bacterial DNA isolation from human fecal and mucosal samples. His publication trends reveal strong focus on Microbiome responses to dietary interventions (fiber, almonds, purified diets) Longitudinal biomarker discovery using interpretable machine learning Clinical applications in hypertension, bariatric surgery, and anorexia nervosa Cross-species validation through murine models Award Highlights: CGIBD Pilot and Feasibility Award (2012) Dr. Carroll maintains active collaborations across multiple disciplines including gastroenterology, immunology, and computational biology. His work integrates molecular techniques with clinical studies to develop nutritional therapies for gastrointestinal diseases. Current research examines microbial contributions to weight regulation post-bariatric surgery and mechanisms underlying microbiome-mediated blood pressure control. The Carroll Lab operates within the MBRB building facility, conducting translational research bridging basic microbial science with clinical applications in metabolic and gastrointestinal disorders.

C. Brooks Mobleyمشاهده پروفایل

استادیار بالینی

• Skeletal Muscle Physiology
• Molecular Mechanisms of Exercise Training
• Sports Supplements
• +۳ مورد دیگر

Dr. C. Brooks Mobley is an Assistant Clinical Professor at the School of Kinesiology, Auburn University. He directs the TigerFit Health & Fitness Laboratory and serves as Associate Director of the Nutrabolt Applied and Molecular Physiology Lab. With a Ph.D. in Kinesiology from Auburn University and postdoctoral training at the University of Kentucky, he specializes in skeletal muscle physiology and sports nutrition research. B.S. in Animal & Dairy Sciences (Auburn University) M.Ed. in Exercise Physiology (Auburn University) Ph.D. in Kinesiology (Auburn University) Postdoctoral Fellowship at University of Kentucky's College of Medicine His research explores molecular mechanisms of muscle plasticity, focusing on: Cellular adaptations to exercise training Ergogenic effects of sports supplements Muscle atrophy prevention strategies Mechanisms of skeletal muscle hypertrophy Angiogenesis in recovery scenarios Muscle-bone interaction dynamics Recent publications demonstrate expertise in: Mitochondrial adaptations to resistance training Epigenetic regulation of muscle growth Microbiome-exercise interactions Proteomic responses to disuse atrophy Firefighting occupational physiology Supplement efficacy studies Laboratory Leadership: TigerFit Health & Fitness Laboratory Nutrabolt Applied and Molecular Physiology Lab

Ralf Herwigمشاهده پروفایل

پژوهشگر

• Computational Biology
• Bioinformatics
• Systems Biology
• +۵ مورد دیگر

Dr. Ralf Herwig is a computational biologist at the Max Planck Institute for Molecular Genetics in Berlin, Germany. His work focuses on statistical methods for integrative analysis of gene expression, proteomics, and metabolomics data to model biological processes in human diseases like cancer and diabetes. He develops tools such as ConsensusPathDB for molecular interaction networks and IsoTools for long-read RNA-seq analysis. Education: Diploma in mathematics (Free University of Berlin), PhD in mathematics/statistics (FU Berlin) on clustering algorithms and information-theoretic methods. Research Interests include computational network biology, multi-omics data integration, machine learning for cancer survival predictions, and alternative splicing analysis. His group pioneered network propagation frameworks to explain drug toxicity and black-box ML models. Key Publications cover deep learning in drug combinations, long-read sequencing for cancer isoforms, and systems biology approaches to metabolic disorders. Tools developed by Herwig's lab are widely cited (~2,500 citations for ConsensusPathDB). Labs & Collaborations: Leads the Herwig Lab, collaborating on projects involving cancer, diabetes, and cardiotoxicity. The lab maintains critical computational resources for the biomedical community.

• Cardiovascular Imaging
• Translational Research
• Molecular Imaging
• +۹ مورد دیگر

Dr. Albert J. Sinusas is a Professor of Medicine (Cardiology) , Radiology & Biomedical Imaging , and Biomedical Engineering at Yale University . He serves as Director of the Yale Translational Research Imaging Center (Y-TRIC) and Advanced Cardiovascular Imaging at Yale New Haven Hospital. Education: BS from Rensselaer Polytechnic Institute (1979), MD from University of Vermont (1983), Internal Medicine training at University of Oklahoma (1986), Cardiology/Nuclear Cardiology at University of Virginia (1989) Dr. Sinusas specializes in non-invasive cardiovascular imaging with expertise in PET/CT, SPECT/CT, echocardiography, and MR imaging . His research focuses on molecular imaging of myocardial injury , angiogenesis , post-infarction remodeling , and deep learning applications in cardiac diagnostics. He has pioneered multimodality imaging approaches for cardiovascular pathophysiology assessment. Recent publications highlight his work in AI-driven cardiac imaging , novel PET tracers , and medical robotics . His team's 15 most recent articles (2024-2025) span topics from ARDS diagnostics to cardiovascular risk stratification using CT and PET technologies. Scientific Awards: SNMMI Hermann Blumgart Award (2008) Best Doctor in America (2001-2002, 2005-2015) M.A. Privatim from Yale (2006) Robert Wilkinson Lectureship (2014) Interurban Clinical Club membership (2017) As Principal Investigator on multiple NIH grants, Dr. Sinusas directs the NHLBI-funded T32 training program in multimodality cardiovascular imaging. His lab (Y-TRIC) houses state-of-the-art imaging resources including hybrid SPECT/CT , microCT , and 3D ultrasound systems for translational research from animal models to clinical applications.

Kari Alitaloمشاهده پروفایل

استاد

• Cancer Biology
• Angiogenesis
• Lymphangiogenesis
• +۵ مورد دیگر

Kari Alitalo is an Academy Professor and Research Director at HUS Radiology and Pathology, University of Helsinki. He serves as a Supervisor in the Doctoral Programme in Integrative Life Science and the Doctoral Programme in Biomedicine. Alitalo directs the CAN-PRO - Translational Cancer Medicine Program and has led the Cancer Biology Research Programme at the University of Helsinki since 1999. His research primarily focuses on blood and lymphatic vessel growth factors with applications in cancer treatment and cardiovascular diseases. Alitalo's work spans angiogenesis, lymphangiogenesis, molecular biology, and translational medicine. His research group has made significant contributions to understanding vascular endothelial growth factors and their therapeutic applications. Alitalo's publication record shows consistent productivity with approximately 670 research outputs. His recent work (2023-2025) demonstrates continued focus on lymphatic system biology, vascular growth factors, and their therapeutic applications in cancer and cardiovascular diseases. The publications reveal a strong emphasis on molecular mechanisms of lymphangiogenesis, tumor angiogenesis, and potential therapeutic interventions. A.I. Virtanen Prize (2013) Biomedicum Helsinki lecture and Medal (2010) Eric K Fernström Foundation's Nordic Prize (2005) Finnish Science Prize (2013) Louis-Jeantet Prize For Medicine (2006) Professor Alitalo has supervised numerous doctoral students, with 52 dissertation supervisor or co-supervisor activities documented. He currently leads multiple active research projects including Cancer Foundation 2025/Alitalo, Biocenter Finland FIRI2023, and Juselius 2023-2026. His research group continues to explore vascular biology with significant implications for cancer treatment and cardiovascular medicine.

Jessica D. Rosardaمشاهده پروفایل

استادیار

• Cellular Stress
• Signal Transduction
• Chemical Biology
• +۵ مورد دیگر

Jessica D. Rosarda PhD is an Assistant Professor in the Department of Anatomy, Physiology and Genetics at the Uniformed Services University (USU) of the Health Sciences School of Medicine in Bethesda, MD. She leads a research laboratory focused on cellular stress mechanisms in military-relevant disorders. PhD in Chemical and Biological Sciences, The Scripps Research Institute (2023) MSc in Pharmacy, University of Florida (2013) BSc in Biology, Washington and Lee University (2010) Dr. Rosarda's research centers on cellular stress response pathways, particularly how cells respond to stress through signaling mechanisms that can either protect or damage tissues. Her work spans chemical biology, molecular medicine, neuroscience, and molecular/cell biology with a focus on proteostasis, unfolded protein response, and stress signaling dynamics in disease contexts. She investigates how imbalances in these pathways contribute to conditions ranging from retinal degeneration to traumatic brain injury, with particular relevance to military medicine. Analysis of Dr. Rosarda's publication record reveals a strong focus on stress response pathways, particularly the unfolded protein response and integrated stress response. Her work demonstrates how perturbations in proteostasis contribute to diverse pathologies including neurodegeneration, amyloidosis, and inflammatory conditions. She employs chemical biology approaches to develop therapeutic strategies targeting these pathways, with several publications on pharmacological modulators of stress responses. Dr. Rosarda maintains an active research program with numerous publications in high-impact journals including Nature Communications, Cell Chemical Biology, and ACS Chemical Biology. Her work frequently involves collaborations with the Wiseman laboratory and other researchers in the fields of proteostasis and stress response. Dr. Rosarda's laboratory at USU focuses on defining stress pathway signaling dynamics in military-relevant disorders, determining the metabolic factors that govern these stress responses, and identifying novel approaches for resolving toxic stress involved in both acute and chronic conditions.

Vladan Koncarمشاهده پروفایل

استاد

• Smart Textiles
• Wearable Technology
• E-Textiles
• +۵ مورد دیگر

Vladan Koncar is a Full Professor and Research Supervisor at École Nationale Supérieure des Arts et Industries Textiles (ENSAIT), where he directs the GEMTEX laboratory and international relations. His research spans smart textiles, e-textiles, wearable sensors, and energy-harvesting systems, with applications in healthcare, military, and environmental monitoring. Research Interests: Koncar's work focuses on three primary themes: (1) Smart textile design for medical/safety applications; (2) Energy harvesting via textile NFC antennas and metamaterials; (3) Standardization of e-textile reliability and testing. His innovations include textile-based ECG monitors, airflow sensors, and photodynamic therapy fabrics. Projects & Grants: He coordinates major EU initiatives (e.g., ETEXWeld, MAPICC 3D) and industrial collaborations with Petit Bateau and @Health. Key projects involve developing instrumented textiles for healthcare, dynamic lighting systems, and filtration monitoring. Honors: Ordre des Palmes Académiques, Chevalier (French Prime Minister Award, 2019) IPC Golden Gnome & Rising Star Awards (2021-2022) Doctor Honoris Causa (Gheorghe Asachi University, 2010) Annual PEDR Award for PhD supervision since 1995 Labs & Teams: Leads the Human Centered Design Group at GEMTEX, specializing in textile-electronics integration. The lab focuses on structural health monitoring, smart composites, and washable e-textile systems.

Rebecca Schollمشاهده پروفایل

دانشیار

• Pediatric Anesthesiology
• Cardiovascular Anesthesiology
• Medical Education
• +۲ مورد دیگر

Dr. Rebecca Scholl serves as an Associate Professor at The University of Texas Health Science Center at Houston (UTHealth Houston), holding dual leadership positions as Division Chief and Education Director of Pediatric Cardiovascular Anesthesiology. Her professional focus centers on pediatric cardiovascular anesthesiology , where she oversees clinical operations and educational programs for this specialized field. Dr. Scholl ensures optimal anesthesia care for children undergoing cardiac surgical procedures, addressing the unique physiological challenges presented by pediatric patients with congenital and acquired heart conditions. As Education Director, she develops comprehensive training curricula for medical students, residents, and fellows, emphasizing competency-based assessment and specialized techniques for pediatric cardiac anesthesia. Her work bridges clinical practice with medical education, contributing to the advancement of standards in this highly specialized discipline.

• Thrombosis
• Haematology
• Cardiovascular Medicine
• +۵ مورد دیگر

Professor Denise Jackson is a faculty member in the Department of Health and Biomedical Sciences at RMIT University, Bundoora West campus. She serves as the Head of the Thrombosis and Vascular Biology laboratory and holds an honorary fellowship from the National Health and Medical Research Council (NHMRC). Her research focuses on thrombosis mechanisms, platelet biology, and immunoreceptor roles in infection and immunity. She coordinates courses such as MEDS1142 Medical Informatics, BUSM3220 Medical Laboratory Quality Systems, and ONPS2153 Medical Informatics and Laboratory Management. Research Interests: Professor Jackson’s work spans thrombosis, platelet function, mouse models of thrombus formation, and the molecular mechanisms of immunoreceptors in pathogens. Her team investigates tetraspanins’ role in blood clot regulation and signaling pathways in platelets. Key projects include studying tyrosine kinase inhibitors’ effects on haemostasis and exploring immunoreceptor crystal structures for drug design. Professional Involvement: She reviews grants for NHMRC, National Heart Foundation, and international bodies like the Wellcome Trust and NSF. She also serves as a reviewer for journals including Nature and Blood . Student Supervision: Principal supervisor of 12 Honours, 3 Masters, and 4 PhD students. Labs/Teams: Leads the Thrombosis and Vascular Biology lab, collaborating on drug development and thrombosis prevention strategies.

Federica Violaمشاهده پروفایل

پژوهشگر

• Cardiovascular Imaging
• 4D Flow MRI
• Cardiovascular Modeling
• +۵ مورد دیگر

Federica Viola is a Researcher at Linköping University, affiliated with the Department of Health, Medicine and Caring Sciences (HMV) and the Division of Diagnostics and Specialist Medicine (DISP). She is part of the Cardiovascular Magnetic Resonance Group (CMR) and the HEART4FLOW initiative. Her primary research focuses on improving cardiovascular 4D flow MRI data quality, hemodynamic modeling, and applying deep learning techniques for automated analysis in clinical settings. Key affiliations include the Center for Medical Image Science and Visualization (CMIV), which develops advanced imaging tools for healthcare. She collaborates with faculty members such as Professors Tino Ebbers, Petter Dyverfeldt, and Carljohan Carlhäll on projects integrating imaging and computational models to study cardiovascular diseases like hypertension and diabetes. Her research emphasizes personalized medicine, combining 4D flow MRI with mathematical models to assess diastolic function, quantify blood flow dynamics, and evaluate treatment effects. Recent work addresses challenges in reproducibility of cardiac models and automated segmentation using AI. Her contributions span cardiovascular imaging technology, hemodynamic analysis, and interdisciplinary collaborations in the Circulation and Metabolism (CircM) strategic network. She actively publishes in journals like Scientific Reports , Journal of Cardiovascular Magnetic Resonance , and Frontiers in Cardiovascular Medicine .

Miles De Blasioمشاهده پروفایل

پژوهشگر ارشد

• Diabetes
• Cardiomyopathies
• Diabetic Complications
• +۶ مورد دیگر

Miles De Blasio is a Research Fellow in Drug Discovery Biology at Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. He also holds adjunct and honorary roles as an Adjunct Research Fellow in Pharmacology at MIPS, Honorary Research Collaborator at the Baker Heart and Diabetes Institute, and Honorary Research Fellow at Monash Clayton’s Department of Pharmacology. His research focuses on novel therapies for diabetic cardiomyopathy, leveraging pharmacological agents and cardiac-selective gene therapies targeting pathways like the hexosamine biosynthesis pathway and adiponectin signaling. De Blasio earned his PhD in 2004 from the University of Adelaide, studying diabetes and obesity origins in fetal growth-restricted sheep. He later worked at the University of Cambridge, exploring fetal leptin’s role in lung and heart development, before shifting to diabetic cardiomyopathy in 2015. Since 2020, he leads MIPS’ efforts to develop cardioprotective treatments. His research interests emphasize translational cardiology and metabolic disease, with a focus on sex-specific differences, preclinical models, and therapeutic interventions. Projects include developing mouse models for diabetic cardiomyopathy and investigating next-generation glucose-lowering therapies’ cardiac benefits. He has secured over $7 million in grants as a Chief Investigator and supervised 10 PhD and 15 Honours students. His work contributes to UN Sustainable Development Goals related to health and well-being. Key Awards: Novartis Junior Investigator Award (Finalist, 2001) Ross Wishart Award (Finalist, 2001) Second Place, IGF Down Under Symposia Oral Presentation (2006) Second Place, GH-IGF International Conference Oral Presentation (2004) New Investigator Award, PSANZ (2002) Advising & Grants: De Blasio has supervised numerous students and secured major funding through NHMRC grants and Diabetes Australia. His labs, including the Cardio-Metabolic Physiology Lab and co-headed Heart Failure Pharmacology Lab, drive interdisciplinary research in drug discovery and cardiac protection. Labs & Collaborations: He leads the Cardio-Metabolic Physiology Laboratory at MIPS, collaborating with institutions like the Baker Heart and Diabetes Institute. Research spans cellular/molecular cardiology, mitochondrial function, and gene therapy applications in diabetes-related heart failure.

• Diabetes
• Cardiovascular Outcomes
• Diabetic Nephropathy
• +۵ مورد دیگر

Professor Steve Bain is a Professor in Medicine (Diabetes) at Swansea University, affiliated with the School of Biomedical Sciences and the Swansea University Medical School. He holds dual roles as Assistant Medical Director for Research & Development at Swansea Bay University Health Board and Clinical Director of the Diabetes Research Unit. His career spans academic research, clinical practice, and healthcare policy. Prof. Bain completed his undergraduate studies at St John's College, Cambridge, and clinical training at King's College Hospital, London. He has held academic positions at the University of Birmingham (Reader in Diabetic Medicine) before moving to Swansea in 2005 as a Chair in Medicine. His clinical expertise includes diabetes management, nephropathy, and novel therapies. Research interests focus on diabetes genetics, cardiovascular outcomes, and kidney disease. He leads multi-center trials (e.g., ONWARDS, SOUL) and chairs the ILS Joint Clinical Research Facility Board. Awards include Fellowship of the Royal College of Physicians (1996). He advises national bodies like the UK Human Genetics Commission and contributes to guidelines (e.g., ABCD-UKKA kidney disease management). His teaching includes leading the Diabetes Practice Masters program and courses on diabetes epidemiology and therapeutics.

Sheleigh Lawlerمشاهده پروفایل

استاد

• Health Psychology
• Public Health
• Health Promotion
• +۷ مورد دیگر

Professor Sheleigh Lawler is a health psychology expert and Head of the Faculty of Health, Medicine and Behavioural Sciences at The University of Queensland. Her research focuses on health behaviors, psychosocial factors, and communication strategies in public health contexts. She leads interdisciplinary teams addressing chronic disease prevention, Indigenous health equity, and behavioral interventions. She holds a PhD from The University of Auckland and has extensive experience in program evaluation, including the '10,000 Lives' smoking cessation initiative and cancer screening equity projects. Education: Bachelor of Arts, The University of Auckland Masters (Coursework), The University of Auckland Doctor of Philosophy, The University of Auckland Research Interests: She investigates psychosocial variables influencing health behaviors, blended learning pedagogy in public health, and behavioral interventions for chronic diseases. Her work emphasizes health equity, particularly for Indigenous populations, and integrates mHealth/eHealth solutions. Grants and Funding: Current NHMRC Synergy Grant (2024–2029): Achieving Equity in Cancer Screening for First Nations Peoples Queensland Health Grant (2023): Tobacco Reduction Reforms and Skin Cancer Prevention Past NHMRC Project Grant (2008–2013): Telephone Counselling for Diabetes Advising and Supervision: Supervises PhD and Master's students on topics like cancer survivorship care, mHealth for hypertension management, and AI-driven smoking cessation tools. Current projects include evaluating social inclusion programs and Indigenous cancer screening equity. Labs/Teams: Active in initiatives such as the 'Stepping Stone Clubhouse' mental health program evaluation and the development of the Quin chatbot for smoking cessation. Collaborates with government agencies and industry on public health campaigns.

Anne-Virginie SALSACمشاهده پروفایل

پژوهشگر

• Bioengineering
• Biomechanics
• Microfluidics
• +۵ مورد دیگر

Anne-Virginie SALSAC is a leading researcher in bioengineering and biomechanics at the University of Technology of Compiègne (UTC), France. She heads the Biomechanics and Bioengineering Laboratory (BMBI, UMR CNRS 7338) and has held an ERC Consolidator Grant (2017) from the European Research Council for her work on multiphysics modeling of microcapsules. Her research focuses on numerical simulation, microfluidics, and bioartificial capsule design for biomedical applications, including hemodynamics in vascular systems and minimally invasive therapies. She has pioneered techniques for microcapsule characterization and sorting, with applications in drug delivery and tissue engineering. SALSAC has collaborated internationally with institutions like Sorbonne Université, University College London, and Queen Mary University of London. Education: Advanced training in bioengineering, with postdoctoral experience in fluid mechanics and biomedical systems. Teaching: Leads graduate courses in mechanical properties of biological materials, microfluidics, and vascular flow modeling at UTC. Previously taught at UC San Diego and University College London. Awards: ERC Consolidator Grant (2017), European scholarship for excellence (2018). Her research integrates experimental and computational methods, emphasizing real-time prediction of capsule deformation and fluid-structure interactions. Key projects include the ERC-funded MultiphysMicroCaps initiative, which explores multiscale modeling of microcapsules under physiological flows. She has developed novel microfluidic tools for capsule sorting and mechanical property analysis, published in top journals like Physical Review E and Journal of Fluids and Structures . SALSAC advocates for scientific mediation, organizing international symposia such as the DynaCaps conference, and has engaged in public outreach via television and media features. Her work bridges fundamental research and clinical applications, with patents on microcapsule fabrication and embolization techniques.